Primary CNS lymphoma: a clinician's guide

被引：0

作者：

Schaefer, Niklas ^{[1
]}

Glas, Martin ^{[1
,2
]}

Herrlinger, Ulrich ^{[1
]}

机构：

[1] Univ Hosp Bonn, Dept Neurol, Div Clin Neurooncol, Bonn, Germany

[2] Univ Bonn, Inst Reconstruct Neurobiol & Stem Cell Pathol Lif, Bonn, Germany

来源：

EXPERT REVIEW OF NEUROTHERAPEUTICS | 2012年 / 12卷 / 10期

关键词：

autologous stem cell transplantation; HD-MTX; intraventricular therapy; lymphoma; neurotoxicity; PCNSL; polychemotherapy; NERVOUS-SYSTEM LYMPHOMA; HIGH-DOSE METHOTREXATE; WHOLE-BRAIN RADIOTHERAPY; NON-HODGKINS-LYMPHOMA; UNDER-THE-CURVE; POLYMERASE-CHAIN-REACTION; STEM-CELL RESCUE; QUALITY-OF-LIFE; TERM-FOLLOW-UP; ELDERLY-PATIENTS;

D O I：

10.1586/ERN.12.120

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Expert Rev. Neurother. 12(10), 1197-1206 (2012) Primary CNS lymphoma is a high malignant disease of the brain which can lead rapidly to death if diagnosis and/or the start of treatment is delayed. The age at time of diagnosis is a strong factor influencing prognosis so that in younger patients <65 years of age long-term survival may be achieved in a substantial percentage of patients, while in elderly patients long-term survival is seen much more rarely. First-line therapy consists of high-dose methotrexate-based (poly) chemotherapy. This review provides an overview of clinical presentation, steps to diagnosis, detailed information about current treatment concepts and specific information for particular clinical situations.

引用

页码：1197 / 1206

页数：10

共 50 条

[31] Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma
Grommes, Christian
Rubenstein, James L.
DeAngelis, Lisa M.
Ferreri, Andres J. M.
Batchelor, Tracy T.
NEURO-ONCOLOGY, 2019, 21 (03) : 296 - 305
[32] Age, gender, and racial differences in incidence and survival in primary CNS lymphoma
Villano, J. L.
Koshy, M.
Shaikh, H.
Dolecek, T. A.
McCarthy, B. J.
BRITISH JOURNAL OF CANCER, 2011, 105 (09) : 1414 - 1418
[33] Progress in primary CNS lymphoma
O'Brien, Peter C.
Seymour, John F.
LANCET, 2009, 374 (9700) : 1477 - 1478
[34] Primary CNS lymphoma - an update
Soussain, Carole
Houillier, Caroline
Choquet, Sylvain
Hoang-Xuan, Khe
BULLETIN DU CANCER, 2014, 101 (03) : 314 - 324
[35] Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion- Weighted MRI
Wieduwilt, Matthew J.
Valles, Francisco
Issa, Samar
Behler, Caroline M.
Hwang, James
McDermott, Michael
Treseler, Patrick
O'Brien, Joan
Shuman, Marc A.
Cha, Soonmee
Damon, Lloyd E.
Rubenstein, James L.
CLINICAL CANCER RESEARCH, 2012, 18 (04) : 1146 - 1155
[36] Rituximab significantly improves complete response rate in patients with primary CNS lymphoma
Birnbaum, Tobias
Stadler, Elisabeth Anne
von Baumgarten, Louisa
Straube, Andreas
JOURNAL OF NEURO-ONCOLOGY, 2012, 109 (02) : 285 - 291
[37] Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma
Lin, Chia-Hsin
Yang, Ching-Fen
Yang, Huai-Che
Fay, Li-Yu
Yeh, Chiu-Mei
Kuan, Ai-Seon
Wang, Hao-Yuan
Gau, Jyh-Pyng
Hsiao, Liang-Tsai
Chiou, Tzeon-Jye
Chen, Po-Min
Liu, Yao-Chung
Ko, Po-Shen
Liu, Jin-Hwang
Liu, Chia-Jen
JOURNAL OF CANCER, 2019, 10 (17): : 3958 - 3966
[38] The role of whole brain radiation in primary CNS lymphoma
Kasenda, Benjamin
Loeffler, Jay
Illerhaus, Gerald
Ferreri, Andres J. M.
Rubenstein, James
Batchelor, Tracy T.
BLOOD, 2016, 128 (01) : 32 - 36
[39] Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma
Kreher, Stephan
Joehrens, Korinna
Strehlow, Felicitas
Martus, Peter
Borowiec, Kathrin
Radke, Josefine
Heppner, Frank
Roth, Patrick
Thiel, Eckhard
Pietsch, Torsten
Weller, Michael
Korfel, Agnieszka
NEURO-ONCOLOGY, 2015, 17 (07) : 1016 - 1021
[40] Advances in therapeutic strategies for primary CNS B-cell lymphomas
Ramadan, Safaa
Radice, Tommaso
Ismail, Ahmed
Fiori, Stefano
Tarella, Corrado
EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (04) : 295 - 304

← 1 2 3 4 5 →